Skip to Main Content

Paper Details

Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration.
NPJ Precis Oncol
4
2023
BARD1, BRCA, BRCA1, BRCA1/2, BRCA1/2 haploinsufficiency, BRCA1/2 mutations, GI (, GI malignancies, HR gene, HRD, Homologous recombination deficiency, RECQL5, RNA, SBS3, Tumors, XRCC2, advanced GI and thoracic cancers, gastrointestinal (GI) and thoracic malignancies, gastrointestinal and thoracic cancers, homologous recombination deficiency, patients, platinum, telomeric, thoracic (n, tumors, wild-type allele
Author NameAffiliation
Janessa Laskin
Marco A Marra
Marco A MarraUniversity of British Columbia
Marco A Marra
Marco A MarraUniversity of British Columbia
Steven J M Jones
Steven J M JonesUniversity of British Columbia
Steven J M JonesSimon Fraser University
Steven J M Jones
Steven J M JonesUniversity of British Columbia
Steven J M JonesSimon Fraser University
  • 1 - 11

Datasets

Release 1.2